PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 1 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $615,261 | -35.4% | 73,684 | -0.2% | 0.12% | -32.0% |
| Q2 2023 | $951,875 | +17.0% | 73,846 | -0.5% | 0.18% | +6.5% |
| Q1 2023 | $813,659 | +35.4% | 74,239 | +1.0% | 0.17% | +23.2% |
| Q4 2022 | $601,058 | +25.2% | 73,479 | -11.1% | 0.14% | +11.3% |
| Q3 2022 | $480,000 | +45.5% | 82,662 | +10.8% | 0.12% | +49.4% |
| Q2 2022 | $330,000 | -52.4% | 74,573 | +1.7% | 0.08% | -46.1% |
| Q1 2022 | $693,000 | -52.9% | 73,295 | +2.0% | 0.15% | -54.2% |
| Q4 2021 | $1,470,000 | -21.2% | 71,837 | -1.7% | 0.34% | -23.6% |
| Q3 2021 | $1,866,000 | -26.6% | 73,046 | +0.4% | 0.44% | -30.9% |
| Q2 2021 | $2,543,000 | +10.4% | 72,720 | +3.7% | 0.64% | +4.1% |
| Q1 2021 | $2,304,000 | -2.0% | 70,132 | +9.4% | 0.61% | +13.1% |
| Q4 2020 | $2,352,000 | +317.0% | 64,100 | +12.3% | 0.54% | +258.3% |
| Q3 2020 | $564,000 | – | 57,100 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HAVENS ADVISORS LLC | 638,000 | $4,613,000 | 4.46% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 6,064,035 | $43,843,000,000 | 3.34% |
| STANSBERRY ASSET MANAGEMENT, LLC | 1,022,262 | $7,391,000 | 2.54% |
| HighVista Strategies LLC | 378,479 | $2,736,000 | 2.23% |
| Versor Investments LP | 3,117,632 | $22,540,000 | 2.14% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 1,627,677 | $11,768,000 | 1.84% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,110,666 | $8,030,000 | 1.71% |
| Magnetar Financial LLC | 8,217,938 | $59,416,000 | 1.53% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 6,072,459 | $43,905,000 | 1.45% |
| WATER ISLAND CAPITAL LLC | 7,247,354 | $52,398,000 | 1.43% |